Join the Oncology Voice Network. Join for Free
 Season 2, Episode 5: Embracing Opportunity with Tonia Nesheiwat

Season 2, Episode 5: Embracing Opportunity with Tonia Nesheiwat


Share This Article


In this episode of the Pharmaverse podcast, our host Michael Pietrack interviews Tonia Nesheiwat, VP of Medical Affairs at Caribou Biosciences. Covering everything from baseball teams, inspiring family journey to America, and of course the latest in the Pharmaverse. Together, they delve into Tonia's leadership style shaped by sports and family values. Tonia shares insights on the importance of mentorship, the challenges in medical affairs, and advice for aspiring leaders in the pharmaceutical industry. "I want to coach them through it." Tonia stresses the importance of working through issues, and keeping the eye on the ball. The conversation highlights the significance of hard work, the human element in leadership, and the need for continuous personal and professional growth. All the while, with a patients first mindset! Tune in for another great episode.

Be sure to subscribe!

Key Moments:

👨‍👩‍👦 Leadership traits are often instilled early in life.

👩‍🏭 Family sacrifices can shape one's work ethic and values. 

⚾ Sports can provide foundational leadership skills.

📈 Competition should be with oneself, not others.

🤝Mentorship is crucial for personal and professional growth.

📲 Effective communication is key in medical affairs.

💌 Embrace opportunities outside of your comfort zone.

📚 Education is a lifelong journey.

💉 The pharmaceutical industry is competitive but offers niches.

💕Leaders should focus on the human element of their teams. 

Watch on YouTube

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Article
Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2
OVN Avatar Guillaume Beinse, MD, Virgile Tellier, Valentin Charvet, MSc, Eric Deutsch, MD, PhD, Isabelle Borget, PharmD, PhD, Christophe Massard, MD, PhD., Antoine Hollebecque, MD, PhD, and Loic Verlingue, MD

Prediction of Drug Approval After Phase I Clinical Trials in Oncology: RESOLVED2

Article
Oncology approvals in 2020: a year of firsts in the midst of a pandemic
OVN Avatar Laleh Amiri-Kordestani & Richard Pazdur

Oncology approvals in 2020: a year of firsts in the midst of a pandemic

Article
Real-World Evidence in Oncology: Opportunities and Limitations
OVN Avatar Massimo Di Maio, Francesco Perrone, Pierfranco Conte

Real-World Evidence in Oncology: Opportunities and Limitations

Article
Accelerated drug approvals in oncology: Pros and cons
OVN Avatar Thakur, Sayanta & Lahiry, Sandeep

Accelerated drug approvals in oncology: Pros and cons

Article
Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives
OVN Avatar Jaques van Heerden, MD, Mohamed Zaghloul, MD, Anouk Neven, MSc, Teresa de Rojas, MD, PhD, Jennifer Geel, MD, Catherine Patte, MD, Joyce Balagadde-Kambugu, MD, Peter Hesseling, MD, Francine Tchintseme, MD, Eric Bouffet, MD, and Laila Hessissen, MD

Pediatric Oncology Clinical Trials and Collaborative Research in Africa: Current Landscape and Future Perspectives

Podcast
Patient Education for Next-Generation Sequencing to Guide Cancer Therapy
OVN Avatar The Oncology Nursing Podcast

Patient Education for Next-Generation Sequencing to Guide Cancer Therapy

Explore OVN